Ongoing, recruitingTherapeutic exploratory (Phase II)Interventional

Phase 2a, double-blind, randomized, placebo-controlled trial of methylprednisolone versus placebo in patients with cognitive deficits in post-COVID-19 syndrome (PCS) - PoCoVIT

This research, named PoCoVIT, is a study for people who are still experiencing problems like memory issues and 'brain fog' after having COVID-19. These lingering problems are sometimes called 'Post-COVID-19 Syndrome'. The study aims to find out if a medicine called methylprednisolone can help improve these memory difficulties. Participants will either receive the active medicine or a 'dummy pill' (placebo) without knowing which one they have. Researchers will carefully check if there's a significant improvement in how people feel about their memory over eight weeks. The study also looks at other aspects of memory, concentration, fatigue, and general well-being over a longer period.

At a glance

Status

Ongoing, recruiting

Phase

Therapeutic exploratory (Phase II)

Sponsor

Charite Universitaetsmedizin Berlin KöR

Enrolment target

418

Start

21 Jun 2023

Post COVID-19 Syndrome

What is this study about?

Many people who have had COVID-19 find themselves struggling with what's often called 'brain fog' or difficulty with their memory. This can be really frustrating and affect daily life. This study, called PoCoVIT, wants to see if a medicine called methylprednisolone could help with these types of memory problems in people who have Post-COVID-19 Syndrome.

Methylprednisolone is a type of medicine that can reduce inflammation in the body. Researchers want to know if it can specifically help improve how well people feel their memory is working. To do this fairly, some people in the study will get the actual medicine, and others will get a placebo, which looks just like the medicine but doesn't contain any active ingredients. Neither the participants nor the doctors will know who is getting which, so everyone's experience can be judged without bias.

The main thing the study wants to find out is if people feel a lot more satisfied with their memory after taking the study treatment for eight weeks. They will also look at how memory changes over a longer time, and if the treatment affects other things like how tired people feel, their mood, and their general quality of life. This kind of research is really important to find new ways to help people recover from the long-term effects of COVID-19.

Key takeaways

This study investigates a medicine for memory problems after COVID-19.
It compares active medicine (methylprednisolone) with a dummy pill.
Focus is on improving satisfaction with memory over 8 weeks.
The study includes adults aged 18 and over.
Participation involves taking medication and regular check-ups for up to a year.

Who may be eligible?

This study is looking for adult volunteers, aged 18 years or older, regardless of their gender. If you've been experiencing ongoing health problems, especially memory issues or 'brain fog', after having COVID-19, you might be able to take part.

To be considered for this study, you usually need to meet certain health criteria. These are put in place by the research team to make sure the study is safe for everyone involved and that the results are clear and useful. For example, specific medical conditions or other medicines you're taking might affect whether you can join.

The best way to find out if you're a good fit for this study is to speak with your doctor or the study team directly. They can go through all the detailed requirements with you and answer any questions you have about your personal health situation.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Have you had COVID-19 and are now experiencing ongoing issues like 'brain fog' or memory problems?
Are you generally well enough to attend regular clinic visits?
Are you willing to take a study medication, which might be a dummy pill?
Are you able to commit to follow-up visits for up to one year?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you'll be given either the study medicine (methylprednisolone) or a dummy pill (placebo) to take. You won't know which one you're receiving, and neither will the study doctors. You'll take the medication for a set period.

Throughout the study, you'll have several visits to the clinic. At these visits, doctors and nurses will check your health, ask you questions about your memory and how you're feeling, and you might complete some questionnaires and short tests. These assessments will help the researchers understand if the treatment is having any effect. Some of these checks will happen at the start, at 8 weeks, at 20 weeks, and then again at 52 weeks to see how you're doing over time. The total duration for follow-up could be up to a year.

Potential risks and benefits

Participating in research studies like this can potentially offer some benefits, such as contributing to medical knowledge that could help others with Post-COVID-19 Syndrome in the future, and you might receive close medical monitoring. If you receive the active medicine, there's a chance it could help improve your memory symptoms. However, like all medicines, methylprednisolone can have side effects, and since you might receive a dummy pill, there's a chance you won't get any direct benefit from the treatment itself. The study team will explain all known potential side effects. Remember, your participation is completely voluntary, and you have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

—
Unverified
Germany

Common questions

What is Post-COVID-19 Syndrome?

It's when you have symptoms that continue for weeks or months after you've had COVID-19, even if the infection is gone. These can include tiredness, shortness of breath, and 'brain fog'.

What is 'brain fog'?

'Brain fog' is a common term for feeling mentally fuzzy, having trouble concentrating, remembering things, or thinking clearly.

What is a 'dummy pill'?

A 'dummy pill' (or placebo) looks exactly like the actual medicine but doesn't contain any active medicinal ingredients. It helps researchers see if the real medicine is truly effective.

How long will I be in the study?

The main part of the study assessing memory changes is for 8 weeks, but overall follow-up to check on your health and well-being will continue for up to 52 weeks (about a year).

Will I know if I'm getting the medicine or the dummy pill?

No, you won't know. This is called 'double-blind' and it helps make sure the results are as fair and accurate as possible.